MLPA in the initial genetic screening of patients with acute myeloid leukemia

Yahya Dinnar; Hachmeriyan Mari; Ruseva Tsanka; Chervenkov Trifon; Micheva Ilina

doi:10.2478/rjim-2023-0027

Romanian Journal of Internal Medicine (Mar 2024)

MLPA in the initial genetic screening of patients with acute myeloid leukemia

Yahya Dinnar,
Hachmeriyan Mari,
Ruseva Tsanka,
Chervenkov Trifon,
Micheva Ilina

Affiliations

Yahya Dinnar: Department of Medical Genetics, Faculty of Medicine, Medical University of Varna
Hachmeriyan Mari: Department of Medical Genetics, Faculty of Medicine, Medical University of Varna
Ruseva Tsanka: Laboratory of Medical Genetics, UMHAT St. Marina, Varna
Chervenkov Trifon: Department of Medical Genetics, Faculty of Medicine, Medical University of Varna
Micheva Ilina: Faculty of Medicine, Medical University of Department of Internal Diseases, Varna

DOI: https://doi.org/10.2478/rjim-2023-0027
Journal volume & issue: Vol. 62, no. 1
pp. 44 – 51

Abstract

Read online

This study aimed to assess the effectiveness of multiplex ligase-dependent probe amplification (MLPA) in the initial genetic screening of patients with acute myeloid leukemia (AML) since current risk stratification and clinical management depend on molecular-genetic markers.

Published in Romanian Journal of Internal Medicine

ISSN: 2501-062X (Online)
Publisher: Sciendo
Country of publisher: Poland
LCC subjects: Medicine: Internal medicine
Website: https://sciendo.com/journal/RJIM

About the journal

Abstract

Keywords